Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Scott Askin"'
Autor:
Seya Colloud, Thomas Metcalfe, Scott Askin, Shibeshih Belachew, Johannes Ammann, Ernst Bos, Timothy Kilchenmann, Paul Strijbos, Damien Eggenspieler, Laurent Servais, Chloé Garay, Athanasios Konstantakopoulos, Armin Ritzhaupt, Thorsten Vetter, Claudia Vincenzi, Francesca Cerreta
Publikováno v:
npj Digital Medicine, Vol 6, Iss 1, Pp 1-11 (2023)
Abstract Digital health technology tools (DHTTs) present real opportunities for accelerating innovation, improving patient care, reducing clinical trial duration and minimising risk in medicines development. This review is comprised of four case stud
Externí odkaz:
https://doaj.org/article/96809dd19189420b9cbff01bd079ea62
Autor:
Philipp Bruland, Mark McGilchrist, Eric Zapletal, Dionisio Acosta, Johann Proeve, Scott Askin, Thomas Ganslandt, Justin Doods, Martin Dugas
Publikováno v:
BMC Medical Research Methodology, Vol 16, Iss 1, Pp 1-10 (2016)
Abstract Background Data capture is one of the most expensive phases during the conduct of a clinical trial and the increasing use of electronic health records (EHR) offers significant savings to clinical research. To facilitate these secondary uses
Externí odkaz:
https://doaj.org/article/bfbfc36e140849ccb5427a836149ea84
Autor:
Scott Askin, Spiros Vamvakas, João Duarte, Armin Ritzhaupt, Michael Berntgen, Thomas Metcalfe, Francesca Cerreta
Publikováno v:
Nature reviews. Drug discovery. 19(9)
Regulatory agencies can provide advice to support developers of digital technologies for medicines use, but what are the best strategies to maximize the chance of a successful regulatory interaction? Here, EMA and industry representatives comment on
Autor:
Martin Dugas, Justin Doods, Eric Zapletal, Philipp Bruland, Johann Proeve, Thomas Ganslandt, Mark McGilchrist, Scott Askin, Dionisio Acosta
Publikováno v:
BMC Medical Research Methodology, Vol 16, Iss 1, Pp 1-10 (2016)
BMC Medical Research Methodology
BMC Medical Research Methodology
Background Data capture is one of the most expensive phases during the conduct of a clinical trial and the increasing use of electronic health records (EHR) offers significant savings to clinical research. To facilitate these secondary uses of routin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::985637cc28afb7401b0f26b920c84c94
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/8023
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/8023